Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16224775 | 0.69 | NPC1 (0.48) | ALDH1A1CYP2C19KMT2A | |
| SCHEMBL2395154 | 0.69 | OPRM1 (0.39) | HSD17B10LMNAALDH1A1CYP2D6KMT2A | |
| SCHEMBL2390562 | 0.69 | LMNA (0.37) | LMNAALDH1A1POLB | |
| SCHEMBL3742265 | 0.67 | KMT2A (0.36) | LMNAALDH1A1POLBKMT2APKM | |
| SCHEMBL2394398 | 0.65 | OPRL1 (0.36) | HSD17B10LMNA | |
| SCHEMBL2388734 | 0.65 | OPRL1 (0.36) | HSD17B10LMNA | |
| SCHEMBL27451724 | 0.65 | NPC1 (0.38) | NR3C2ALDH1A1POLBKMT2APKM | |
| SCHEMBL28665811 | 0.64 | — | — | |
| SCHEMBL1643462 | 0.64 | OPRM1 (0.39) | CYP2D6 | |
| SCHEMBL1317731 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013008-B2 | Cyclic amine compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-09-06 | — | — | US | disclosed |